Federal court rejects PhRMA challenge to Medicare drug price negotiation
A federal appeals court on Wednesday ruled against a lawsuit filed by representatives of the pharmaceutical industry challenging the federal Medicare drug price negotiation program, finding that drugmakers are not entitled to sell their products to Medicare at a price they would prefer. The U.S. Court of Appeals for the 5th Circuit affirmed a prior…
The Hill
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from The Hill.
In this story
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
The Hill (thehill.com), a Tier B publisher, filed this report on . CurrentWire published this page 8 minutes later, on .
Signal breakdown
CurrentWire ranked this story 65.7 of 100 in the snapshot this page was rendered from.
- Freshness
- 29.7 of 35
- Source authority
- 14 of 20
- Coverage breadth
- 4 of 20
- Geographic relevance
- 10 of 10
- Story prominence
- 8 of 10
- Velocity
- 0 of 5
Strongest signal: geographic relevance, 10 of 10. How each signal is calculated.
Filed under General · United States · News. Topics extracted from this report, with other live CurrentWire stories mentioning each: United States (84).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.